Semax is not currently available through telos rx. This article states that plainly and explains the actual regulatory and program reasons behind it. It also points to what telos rx does offer today if you are ready to start a compounded peptide protocol.
Semax is not part of the telos rx compounding program, and this article is not an offer to sell it. telos rx currently offers BPC-157, PT-141, NAD+ nasal spray, and sermorelin as compounded protocols today.
The direct answer
No, telos rx does not currently offer Semax in any form, standalone or otherwise. It is not in stock, it is not being prepared for a future release, and there is no confirmed date for that to change.
You can read more about telos rx's current status on the Semax page, which reflects this same status and carries no offer to sell it.
Why Semax is not currently offered
telos rx is reviewing Semax along with several other research peptides, but reviewing is not the same as approving, and no timeline is confirmed. A 2026 review by the FDA's Pharmacy Compounding Advisory Committee produced non-binding recommendations touching several research peptides, Semax among them.
A non-binding recommendation is a step within a longer regulatory process, not a final ruling and not an approval. It did not authorize any pharmacy, telos rx included, to compound Semax on its own.
Compounded medications, including the ones telos rx already offers, are not FDA-approved to begin with. Adding a new peptide is a separate, deliberate program decision layered on top of that baseline reality, not something that happens automatically.
Key takeaway: Semax is not available at telos rx today, there is no confirmed release date, and this status is a program decision rather than a statement about Semax's underlying research value.
What "under review" means
Under review means telos rx is actively evaluating Semax's regulatory status. It also covers whether a verifiable, pharmaceutical-grade supply chain exists, and whether the current body of evidence supports offering it responsibly through a real clinical intake.
None of those questions has a fixed answer today. It is genuinely possible the review eventually concludes in Semax's favor, and it is also genuinely possible it does not. Neither outcome is predictable from where things currently stand.
For background on how compounded medications are regulated more broadly, see the FDA overview of drug compounding.
Why Semax's Russian history doesn't change availability here
Semax has a genuine, decades-long clinical history in Russia, where it has been registered and used as a nasal spray. That history sometimes leads people to assume US availability should follow relatively quickly.
Regulatory approval is jurisdiction-specific, though, and a treatment accepted within one country's medical system does not automatically transfer to another's. telos rx operates within the United States regulatory framework, and that framework has not cleared Semax.
What buying it elsewhere online actually means
Semax is widely sold in the United States online under a "not for human consumption" research-chemical label, a real regulatory category rather than a workaround. That label reflects the fact that the product has not gone through the review a medication requires here.
Buying and using a product sold this way means no pharmacy has verified its purity or sourcing, and no clinical oversight is involved in the transaction. That is precisely the gap telos rx will not participate in, regardless of demand.
General guidance from the NIH on evaluating unregulated health products, in using dietary supplements wisely, is a useful reference point here even though Semax is not a dietary supplement.
What would need to change
Three things would need to align before Semax could become available at telos rx. Clearer, binding regulatory guidance beyond a non-binding recommendation is one. A verified pharmaceutical-grade supply chain and a stronger body of independent human research are the other two.
Even if those three things aligned, telos rx would still apply its own internal clinical review before making a final decision. That review does not happen automatically once external conditions change.
Available today
If your interest in Semax is really about cognitive clarity, focus, or general energy, telos rx currently offers a compounded NAD+ nasal spray with a real clinical intake behind it. It is a different molecule, with its own separate research history.
telos rx will not present NAD+ as a Semax substitute, since it is not one. It is simply a genuine, available option today. If it fits what you are looking for, you can start an intake for NAD+ nasal spray.
How this differs from BPC-157's path to availability
It is worth comparing Semax's current status to a peptide telos rx does compound: BPC-157. BPC-157 has a supply chain telos rx has been able to verify. It also has a body of research telos rx's internal review concluded was sufficient, and a regulatory picture that allowed it to be offered through a real clinical intake.
That does not mean BPC-157 is FDA-approved. It is not, and no compounded medication telos rx offers is. It means BPC-157 cleared the specific internal bar telos rx applies before adding anything to its program, the same bar Semax has not yet cleared.
Looking at that comparison is useful because it demonstrates the bar is real and applied consistently, not an excuse invented specifically for Semax.
Why telos rx avoids projecting a launch date
It would be simpler, from a marketing standpoint, to give Semax an estimated availability window. telos rx deliberately does not do that, because a projected date creates an expectation the underlying regulatory and supply chain realities may not support.
Patients who plan around an unofficial estimate and then watch it slip tend to lose trust, understandably. Avoiding that outcome matters more to telos rx than the short-term benefit of sounding more optimistic than the facts currently allow.
What this status doesn't mean
None of this should be read as a promise that Semax availability is imminent, nor should it be read as a certainty that it will never happen. Both of those are overstatements this article deliberately avoids.
It is entirely possible the regulatory picture, the supply chain, or the evidence base never reaches a point where telos rx adds Semax to its program. It is also possible the picture changes meaningfully within a reasonable window. Neither outcome is predictable from where things stand today.
Staying informed
If you want to track Semax's status, the Semax page is the place telos rx would reflect an actual program change, not a forum thread or a vendor's marketing claim.
In the meantime, primary research remains the most reliable way to understand Semax itself. Searching Semax directly on a database like PubMed will surface published studies rather than secondhand summaries written to sell something.
What to ask before buying it elsewhere
If you are considering a research-chemical vendor selling Semax, a few direct questions are worth asking first. Has the product been independently tested for purity, and can the seller show that documentation.
Is the seller a licensed pharmacy or an unregulated supplier, since those categories carry very different obligations. What recourse exists if the product does not match its labeling. In most cases, a research-chemical vendor cannot answer these questions the way a licensed compounding pharmacy can, which is exactly why telos rx does not operate in that space.
Asking these questions is not about being difficult or unreasonable. It is a reasonable form of due diligence that any vendor genuinely confident in their own product should be able to withstand without hesitation.
Why this article exists
People deserve a direct answer to a simple question. This article is written to give one plainly, rather than burying it in vague language designed to keep hope alive without saying anything concrete.
Semax is simply not available at telos rx today. That fact does not reflect poorly on the peptide's underlying research, and it does not mean the interest behind the original question is unreasonable at all. It simply reflects where regulation, supply, and evidence currently stand, honestly described rather than softened for the sake of a more comfortable, hopeful-sounding answer.
Frequently Asked Questions
Is Semax available at telos rx right now?
No. Semax is not currently part of the telos rx compounding program, and there is no confirmed date for that to change.
Why isn't Semax offered if it has a long history in Russia?
Regulatory approval is jurisdiction-specific. A treatment history in Russia's medical system does not translate into FDA clearance or telos rx's own internal approval in the United States.
Did the 2026 FDA committee review make Semax available?
No. It produced a non-binding recommendation, which is a step in a longer regulatory process, not an approval that authorizes compounding.
Is it safe to buy Semax online labeled for research use?
No pharmacy has verified purity or sourcing for products sold that way, and there is no clinical oversight involved. telos rx does not sell or endorse research-labeled products for personal use.
Will telos rx offer Semax eventually?
Possibly, but there is no confirmed timeline, and this article does not speculate about one.
What can I use today for cognitive or energy support?
telos rx offers a compounded NAD+ nasal spray with a real clinical intake process, available now.
telos rx is LegitScript-certified. Compounded medications are not FDA-approved. Semax is not currently offered by telos rx in any form. This article is general information, not medical advice, and does not replace guidance from your own provider.
Curious about an available option today? Learn about NAD+ nasal spray or explore the full telos rx lineup.